Godshall Douglas Evan

President & CEO, DirectorShockwave Medical, Inc. (SWAV) · full profile →Form 4 · filed Feb 16, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
10
9 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 15, 2024Sell(S)600$235.21$141K164K
Feb 15, 2024Sell(S)200$233.54$47K164K
Feb 15, 2024Sell(S)792$232.74$184K164K
Feb 15, 2024Option exercise(M)10K$3.42$34K173K
Feb 15, 2024Sell(S)560$228.28$128K172K
Feb 15, 2024Sell(S)2K$229.82$512K170K
Feb 15, 2024Sell(S)3K$230.86$646K167K
Feb 15, 2024Sell(S)2K$231.74$460K165K
Feb 15, 2024Sell(S)831$236.13$196K163K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 15, 2024Option exercise(M)10K$0295K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001642545-24-000044) within minutes of acceptance. Every field above traces to the original document. Verify it directly: